Pulmonary metastasectomy for malignant melanoma – Outcome and survival a retrospective analysis

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00012291

Enrollment

Registered

2017-10-18

Start date

2017-10-12

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C34

Interventions

Group 1: The following data will be collected retrospectively: Age, gender, tumor size, primary tumor characteristics, tumor position, complete resection, recurrence, number of metastases, operation d

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with malignant melanoma who underwent a pulmonary metastasectomy at our institution between 2005-2014 in curative intent.

Exclusion criteria

Exclusion criteria: Extrapulmonary disease manifestation, physical condition inadequate for surgery.

Design outcomes

Primary

Measure	Time frame
The primary endpoint is disease free survival and overall survival	—

Secondary

Measure	Time frame
Several subgroups will be investigated with respect to overall survival (one metastasis vs. more than one metastasis; melanoma type).	—

Countries

Germany

Contacts

Public ContactPawel Leskow

UNIVERSITÄTSKLINIKUM FREIBURGDepartment ChirurgieKlinik für Thoraxchirurgie

pawel.leskow@uniklinik-freiburg.de0761/270 24010

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026